| Alberto Gonzalez-bernal, MD | |
|
3443 Dickerson Pk, Suite 680, Nashville, TN 37207 | |
| (615) 865-3322 | |
| (615) 467-6692 |
| Full Name | Alberto Gonzalez-bernal |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 33 Years |
| Location | 3443 Dickerson Pk, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952415499 | NPI | - | NPPES |
| 3877830 | Medicaid | TN | |
| 7100353070 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 36656 (Tennessee) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 36656 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Skyline Medical Center | Nashville, TN | Hospital |
| Jennie Stuart Medical Center | Hopkinsville, KY | Hospital |
| Northcrest Medical Center | Springfield, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Middle Tennessee Pulmonary Associates Llc | 8628090958 | 28 |
News Archive
A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.
The University of Chicago Celiac Disease Center is hosting the 15th International Celiac Disease Symposium (ICDS) on Sept. 22-25, 2013 in Chicago. The symposium is the largest celiac disease and gluten-related disorders conference in the world.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of OPANA® ER (oxymorphone hydrochloride) Extended Release 30mg tablet. In June 2010, the Company was granted final approval for the 5mg, 10mg, 20mg, and 40mg tablets.
Cerebrovascular disease is a leading cause of serious long-term disability, affecting as many as 700,000 people every year.
› Verified 7 days ago
| Entity Name | Middle Tennessee Pulmonary Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215008032 PECOS PAC ID: 8628090958 Enrollment ID: O20101014000119 |
News Archive
A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.
The University of Chicago Celiac Disease Center is hosting the 15th International Celiac Disease Symposium (ICDS) on Sept. 22-25, 2013 in Chicago. The symposium is the largest celiac disease and gluten-related disorders conference in the world.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of OPANA® ER (oxymorphone hydrochloride) Extended Release 30mg tablet. In June 2010, the Company was granted final approval for the 5mg, 10mg, 20mg, and 40mg tablets.
Cerebrovascular disease is a leading cause of serious long-term disability, affecting as many as 700,000 people every year.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alberto Gonzalez-bernal, MD 3443 Dickerson Pk, Suite 680, Nashville, TN 37207 Ph: (615) 865-3322 | Alberto Gonzalez-bernal, MD 3443 Dickerson Pk, Suite 680, Nashville, TN 37207 Ph: (615) 865-3322 |
News Archive
A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.
The University of Chicago Celiac Disease Center is hosting the 15th International Celiac Disease Symposium (ICDS) on Sept. 22-25, 2013 in Chicago. The symposium is the largest celiac disease and gluten-related disorders conference in the world.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of OPANA® ER (oxymorphone hydrochloride) Extended Release 30mg tablet. In June 2010, the Company was granted final approval for the 5mg, 10mg, 20mg, and 40mg tablets.
Cerebrovascular disease is a leading cause of serious long-term disability, affecting as many as 700,000 people every year.
› Verified 7 days ago
Megan Desai, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Spurthi N Bhatt, MD MPH Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 | |
Aladraine Sands, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 275 Cumberland Bnd, Nashville, TN 37228 Phone: -- |